The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells

European Journal of Pharmacology

Volumn 390, Issue 1-2, 2000, Pages 89-94

  Lees, Delphine M ^a   Pallikaros, Zakos ^b   Corder, Roger ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Amersham Biosciences   (United States)

Author keywords

Atherosclerosis; Endothelial cell; Endothelin; Epithelial cell; Inflammation; TNF (tumor necrosis factor) receptor

Indexed keywords

ENDOTHELIN 1; IODINE 125; MEMBRANE RECEPTOR; MUTANT PROTEIN; PROTEIN P55; PROTEIN P75; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CATTLE; CELL CULTURE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR BINDING;

ANIMALS; ANTIGENS, CD; BINDING, COMPETITIVE; CATTLE; CELL LINE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; HUMANS; IODINE RADIOISOTOPES; MUTATION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034712107     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00022-4     Document Type: Article

References (26)

1. Aggarwal B.B., Natarajan K. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Network. 7(2):1996;93-124.
2. Barbara J.A.J., Smith W.B., Gamble J.R., Van Ostade X., Vandenabeele P., Tavernier J., Fiers W., Vadas M.A., Lopez A.F. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants. EMBO J. 13:1994;843-850.
3. Beutler B., Cerami A. The biology of cachectin/TNFα - a primary mediator of the host response. Annu. Rev. Immunol. 7:1989;625-655.
4. Brockhaus M., Schoenfeld H.J., Schlaeger E.J., Hunziker W., Lesslauer W., Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A. 87:1990;3127-3131.
5. Cembrzynska-Nowak M., Szklarz E., Inglot A.D., Teodorczyk-Injeyan J.A. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am. Rev. Respir. Dis. 147:1993;291-295.
6. Clauss M., Grell M., Fangmann C., Fiers W., Scheurich P., Risau W. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: functional analysis of the tumor necrosis factor receptors. FEBS Lett. 390:1996;334-338.
7. Corder R., Carrier M., Khan N., Klemm P., Vane J.R. Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J. Cardiovasc. Pharmacol. 26(S3):1995;S56-S58.
8. Corder R., Harrison V.J., Khan N., Änggård E.E., Vane J.R. Effects of phosphoramidon in endothelial cell cultures on the endogenous synthesis of endothelin-1 and on conversion of exogenous big-endothelin-1 to endothelin-1. J. Cardiovasc. Pharmacol. 28(S8):1993;S73-S76.
9. Darnay B.G., Aggarwal B.B. Early events in TNF signaling: a story of associations and dissociations. J. Leuk. Biol. 61:1997;559-566.
10. Grell M., Douni E., Wajant H., Löhden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:1995;793-802.
11. Haynes W.G., Webb D.J. Endothelin as a regulator of cardiovascular function in health and disease. J. Hypertens. 16:1998;1081-1098.
12. Klemm P., Warner T.D., Hohlfeld T., Corder R., Vane J.R. Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2691-2695.
13. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., Brunett J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 325:1991;997-1001.
14. Lewis M., Tartaglia L.A., Lee A., Bennett G.L., Rice G.C., Wong G.H.W., Chen E.Y., Goeddel D.V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. U. S. A. 88:1991;2830-2834.
15. Loetscher H., Stueber D., Banner D., Mackay F., Lesslauer W. Human tumor necrosis factor α (TNFα) mutants with exclusive specificity for the 55-kDa or 75-kDa receptors. J. Biol. Chem. 268:1993;26350-26357.
16. Mackay F., Loetscher H., Stueber D., Gehr G., Lesslauer W. Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one receptor type, TNF-R55. J. Exp. Med. 177:1993;1277-1286.
17. Marsden P.A., Brenner B.M. Transcriptional regulation of the endothelin-1 gene by TNFα Am. J. Physiol. 262:1992;C854-C861.
18. Mattoli S., Soloperto M., Marini M., Fasoli A. Levels of endothelin in the bronchoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J. Allergy Clin. Immunol. 88:1991;376-384.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
20. Nakano J., Takizawa H., Ohtoshi T., Shoji S., Yamaguchi M., Ishii A., Yanagisawa M., Ito K. Endotoxin and pro-inflammatory cytokines stimulate endothelin-1 expression and release by airway epithelial cells. Clin. Exp. Allergy. 24:1994;330-336.
21. Pinckard J.K., Sheehan K.C.F., Schreiber R.D. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J. Biol. Chem. 272:1997;10784-10789.
22. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
23. Rus H.G., Nisulescu F., Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis. 89:1991;247-254.
24. Schmid E.F., Binder K., Grell M., Scheurich P., Pfizenmaier K. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor α Blood. 86:1995;1836-1841.
25. Tartaglia L.A., Pennica D., Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNFα receptor. J. Biol. Chem. 268:1993;18542-18548.
26. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.